{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:25:34Z","timestamp":1793831134111,"version":"4.6.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"35","license":[{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background and Aims<\/jats:title>\n                  <jats:p>Based on retrospective studies, the 2022 European guidelines changed the definition of post-capillary pulmonary hypertension (pcPH) in heart failure (HF) by lowering the level of mean pulmonary artery pressure (mPAP) and pulmonary vascular resistance (PVR). However, the impact of this definition and its prognostic value has never been evaluated prospectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Stable left HF patients with the need for right heart catheterization were enrolled from 2010 to 2018 and prospectively followed up in this multicentre study. The impact of the successive pcPH definitions on pcPH prevalence and subgroup [i.e. isolated (IpcPH) vs. combined pcPH (CpcPH)] was evaluated. Multivariable Cox regression analysis was used to assess the prognostic value of mPAP and PVR on all-cause death or hospitalization for HF (primary outcome).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Included were 662 HF patients were (median age 63 years, 60% male). Lowering mPAP from 25 to 20 mmHg resulted in +10% increase in pcPH prevalence, whereas lowering PVR from 3 to 2 resulted in +60% increase in CpcPH prevalence (with significant net reclassification improvement for the primary outcome). In multivariable analysis, both mPAP and PVR remained associated with the primary outcome [hazard ratio (HR) 1.02, 95% confidence interval (CI) 1.00\u20131.03, P = .01; HR 1.07, 95% CI 1.00\u20131.14, P = .03]. The best PVR threshold associated with the primary outcome was around 2.2 WU. Using the 2022 definition, pcPH patients had worse survival compared with HF patients without pcPH (log-rank, P = .02) as well as CpcPH compared with IpcPH (log-rank, P = .003).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study is the first emphasizing the impact of the new pcPH definition on CpcPH prevalence and validating the prognostic value of mPAP &amp;gt; 20 mmHg and PVR &amp;gt; 2 WU among HF patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehae467","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T11:20:08Z","timestamp":1721992808000},"page":"3274-3288","source":"Crossref","is-referenced-by-count":37,"title":["Post-capillary pulmonary hypertension in heart failure: impact of current definition in the PH-HF multicentre study"],"prefix":"10.1093","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6243-2544","authenticated-orcid":false,"given":"Charles","family":"Fauvel","sequence":"first","affiliation":[{"name":"Cardiology Department, Rouen University Hospital , F-76000 Rouen ,","place":["France"]},{"name":"Centre de Comp\u00e9tence en hypertension pulmonaire 27\/76, Centre Hospitalier Universitaire Charles Nicolle , F76000 Rouen ,","place":["France"]},{"name":"INSERM U1096, Rouen University Hospital , F-76000 Rouen ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4058-3848","authenticated-orcid":false,"given":"Thibaud","family":"Damy","sequence":"additional","affiliation":[{"name":"R\u00e9seau Cardiogen, Department of Cardiology, Centre Fran\u00e7ais de R\u00e9f\u00e9rence de l\u2019Amylose Cardiaque (CRAC), CHU Henri-Mondor , Cr\u00e9teil ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Berthelot","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Saclay, Facult\u00e9 de M\u00e9decine , Le Kremlin-Bic\u00eatre ,","place":["France"]},{"name":"Cardiology Department, Bic\u00eatre University Hospital , Le Kremlin-Bic\u00eatre ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Bauer","sequence":"additional","affiliation":[{"name":"Centre de Comp\u00e9tence en hypertension pulmonaire 27\/76, Centre Hospitalier Universitaire Charles Nicolle , F76000 Rouen ,","place":["France"]},{"name":"INSERM U1096, Rouen University Hospital , F-76000 Rouen ,","place":["France"]},{"name":"Cardiac Surgery Department, Rouen University Hospital , F-76000 Rouen ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Eicher","sequence":"additional","affiliation":[{"name":"Service de Cardiologie, CHU de Dijon-H\u00f4pital Bocage Central , Dijon ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"de Groote","sequence":"additional","affiliation":[{"name":"CHU Lille, Service de cardiologie , Bd du Professeur Jules Leclercq, F-59000 Lille ,","place":["France"]},{"name":"Inserm U1167, Institut Pasteur de Lille , F-59000 Lille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4742-281X","authenticated-orcid":false,"given":"Jean-No\u00ebl","family":"Trochu","sequence":"additional","affiliation":[{"name":"Nantes Universit\u00e9, CHU Nantes, CNRS, INSERM, l\u2019institut du thorax , Nantes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Picard","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de traitement de l\u2019insuffisance cardiaque, Centre de Comp\u00e9tences de l\u2019Hypertension pulmonaire, H\u00f4pital Cardiologique Haut-L\u00e9v\u00eaque, Centre Hospitalier Universitaire de Bordeaux, Universit\u00e9 de Bordeaux , Bordeaux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Renard","sequence":"additional","affiliation":[{"name":"Service de Cardiologie, Centre R\u00e9gional de Comp\u00e9tences de l\u2019Hypertension Pulmonaire, H\u00f4pital La Timone , Marseille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Bouvaist","sequence":"additional","affiliation":[{"name":"Cardiology Service, Michallon Hospital, Grenoble University Hospital Center , Grenoble ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Logeart","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, Inserm U942, Lariboisi\u00e8re Hospital, AP-HP , 75010 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Roubille","sequence":"additional","affiliation":[{"name":"PhyMedExp, Cardiology Department, University of Montpellier, INSERM U1046, CNRS UMR, 9214, INI-CRT , Montpellier ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Sitbon","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Saclay, Facult\u00e9 de M\u00e9decine , Le Kremlin-Bic\u00eatre ,","place":["France"]},{"name":"Service de Pneumologie et Soins Intensifs Respiratoires, Centre de R\u00e9f\u00e9rence de l\u2019Hypertension Pulmonaire, H\u00f4pital Bic\u00eatre, Assistance Publique H\u00f4pitaux de Paris , Le Kremlin Bic\u00eatre, France"},{"name":"INSERM UMR_S 999 , H\u00f4pital Marie Lannelongue, Le Plessis-Robinson,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3754-1241","authenticated-orcid":false,"given":"Nicolas","family":"Lamblin","sequence":"additional","affiliation":[{"name":"CHU Lille, Service de cardiologie , Bd du Professeur Jules Leclercq, F-59000 Lille ,","place":["France"]},{"name":"Inserm U1167, Institut Pasteur de Lille , F-59000 Lille ,","place":["France"]},{"name":"Universit\u00e9 de Lille , 2 Avenue Eug\u00e8ne Avin\u00e9e, 59120 Loos,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,7,26]]},"reference":[{"key":"2024092614243821600_ehae467-B1","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"2024092614243821600_ehae467-B2","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/eurheartj\/ehv512","article-title":"Left ventricular heart failure and pulmonary hypertension","volume":"37","author":"Rosenkranz","year":"2016","journal-title":"Eur Heart J"},{"key":"2024092614243821600_ehae467-B3","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.jacc.2020.06.069","article-title":"Pulmonary hypertension in HFpEF and HFrEF: JACC review topic of the week","volume":"76","author":"Guazzi","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2024092614243821600_ehae467-B4","doi-asserted-by":"publisher","first-page":"1801897","DOI":"10.1183\/13993003.01897-2018","article-title":"Pulmonary hypertension due to left heart disease","volume":"53","author":"Vachi\u00e9ry","year":"2019","journal-title":"Eur Respir J"},{"key":"2024092614243821600_ehae467-B5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"key":"2024092614243821600_ehae467-B6","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1378\/chest.12-1653","article-title":"Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in \u201cout-of-proportion\u201d pulmonary hypertension","volume":"143","author":"Gerges","year":"2013","journal-title":"Chest"},{"key":"2024092614243821600_ehae467-B7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jchf.2014.07.010","article-title":"The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease","volume":"3","author":"Tampakakis","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2024092614243821600_ehae467-B8","doi-asserted-by":"publisher","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"key":"2024092614243821600_ehae467-B9","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"Eur Heart J"},{"key":"2024092614243821600_ehae467-B10","doi-asserted-by":"publisher","first-page":"e009729","DOI":"10.1161\/JAHA.118.009729","article-title":"Mild pulmonary hypertension is associated with increased mortality: a systematic review and meta-analysis","volume":"7","author":"Kolte","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2024092614243821600_ehae467-B11","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S2213-2600(20)30317-9","article-title":"Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study","volume":"8","author":"Maron","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2024092614243821600_ehae467-B12","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1161\/CIRCULATIONAHA.115.020207","article-title":"Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: insights from the Veterans Affairs clinical assessment, reporting, and tracking program","volume":"133","author":"Maron","year":"2016","journal-title":"Circulation"},{"key":"2024092614243821600_ehae467-B13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2024092614243821600_ehae467-B14","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2024092614243821600_ehae467-B15","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2024092614243821600_ehae467-B16","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1183\/09031936.00145608","article-title":"Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review","volume":"34","author":"Kovacs","year":"2009","journal-title":"Eur Respir J"},{"key":"2024092614243821600_ehae467-B17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/ejhf.192","article-title":"Pulmonary arterial capacitance in patients with heart failure and reactive pulmonary hypertension","volume":"17","author":"Dragu","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2024092614243821600_ehae467-B18","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jjcc.2015.07.015","article-title":"Pulmonary hypertension due to left heart disease: the prognostic implications of diastolic pulmonary vascular pressure gradient","volume":"67","author":"Ibe","year":"2016","journal-title":"J Cardiol"},{"key":"2024092614243821600_ehae467-B19","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/clc.22579","article-title":"Combined post- and precapillary pulmonary hypertension in patients with heart failure","volume":"39","author":"Rezaee","year":"2016","journal-title":"Clin Cardiol"},{"key":"2024092614243821600_ehae467-B20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.healun.2013.11.008","article-title":"Prognostic value of the pre-transplant diastolic pulmonary artery pressure-to-pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension","volume":"33","author":"Tedford","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"2024092614243821600_ehae467-B21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/ejhf.860","article-title":"Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC\/ERS guidelines and insights for future changes","volume":"20","author":"Palazzini","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2024092614243821600_ehae467-B22","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1001\/jamacardio.2018.0128","article-title":"Association between hemodynamic markers of pulmonary hypertension and outcomes in heart failure with preserved ejection fraction","volume":"3","author":"Vanderpool","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2024092614243821600_ehae467-B23","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1093\/eurheartj\/ehad532","article-title":"Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC\/ERS guidelines: the EVIDENCE-PAH UK study","volume":"44","author":"Karia","year":"2023","journal-title":"Eur Heart J"},{"key":"2024092614243821600_ehae467-B24","doi-asserted-by":"publisher","first-page":"e004436","DOI":"10.1161\/CIRCHEARTFAILURE.117.004436","article-title":"Pulmonary effective arterial elastance as a measure of right ventricular afterload and its prognostic value in pulmonary hypertension due to left heart disease","volume":"11","author":"Tampakakis","year":"2018","journal-title":"Circ Heart Fail"},{"key":"2024092614243821600_ehae467-B25","doi-asserted-by":"publisher","first-page":"e004082","DOI":"10.1161\/CIRCHEARTFAILURE.117.004082","article-title":"Hemodynamic phenotyping of pulmonary hypertension in left heart failure","volume":"10","author":"Naeije","year":"2017","journal-title":"Circ Heart Fail"},{"key":"2024092614243821600_ehae467-B26","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1016\/j.jacc.2017.01.051","article-title":"Pulmonary hypertension in heart failure: pathophysiology, pathobiology, and emerging clinical perspectives","volume":"69","author":"Guazzi","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2024092614243821600_ehae467-B27","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1164\/rccm.201503-0529OC","article-title":"Pulmonary hypertension in heart failure. Epidemiology, right ventricular function, and survival","volume":"192","author":"Gerges","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2024092614243821600_ehae467-B28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ahj.2017.06.006","article-title":"Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: similarities and disparities","volume":"192","author":"Adir","year":"2017","journal-title":"Am Heart J"},{"key":"2024092614243821600_ehae467-B29","doi-asserted-by":"publisher","first-page":"1801900","DOI":"10.1183\/13993003.01900-2018","article-title":"Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update","volume":"53","author":"Vonk Noordegraaf","year":"2019","journal-title":"Eur Respir J"},{"key":"2024092614243821600_ehae467-B30","doi-asserted-by":"publisher","first-page":"D100","DOI":"10.1016\/j.jacc.2013.10.033","article-title":"Pulmonary hypertension due to left heart diseases","volume":"62","author":"Vachi\u00e9ry","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2024092614243821600_ehae467-B31","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/CIRCULATIONAHA.116.022362","article-title":"Systemic consequences of pulmonary hypertension and right-sided heart failure","volume":"141","author":"Rosenkranz","year":"2020","journal-title":"Circulation"},{"key":"2024092614243821600_ehae467-B32","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jchf.2013.05.001","article-title":"Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure","volume":"1","author":"Miller","year":"2013","journal-title":"JACC Heart Fail"},{"key":"2024092614243821600_ehae467-B33","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jchf.2015.01.013","article-title":"Pulmonary arterial capacitance is an important predictor of mortality in heart failure with a preserved ejection fraction","volume":"3","author":"Al-Naamani","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2024092614243821600_ehae467-B34","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1002\/ehf2.13386","article-title":"Predictors and prognosis of right ventricular function in pulmonary hypertension due to heart failure with reduced ejection fraction","volume":"8","author":"Schmei\u00dfer","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2024092614243821600_ehae467-B35","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1378\/chest.13-1510","article-title":"Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure","volume":"145","author":"Pellegrini","year":"2014","journal-title":"Chest"},{"key":"2024092614243821600_ehae467-B36","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1002\/ehf2.12785","article-title":"The dangerous and contradictory prognostic significance of PVR&lt;3WU when TAPSE&lt;16 mm in postcapillary pulmonary hypertension","volume":"7","author":"Raiti\u00e8re","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2024092614243821600_ehae467-B37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0735-1097(00)01102-5","article-title":"Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure","volume":"37","author":"Ghio","year":"2001","journal-title":"J Am Coll Cardiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/45\/35\/3274\/59355761\/ehae467.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/45\/35\/3274\/59355761\/ehae467.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T15:38:44Z","timestamp":1727365124000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/45\/35\/3274\/7721307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,26]]},"references-count":37,"journal-issue":{"issue":"35","published-online":{"date-parts":[[2024,7,26]]},"published-print":{"date-parts":[[2024,9,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehae467","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9,14]]},"published":{"date-parts":[[2024,7,26]]}}}